- $4.24m
- $5.03m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.47 | 0.459 | 0.111 | 0 | 0 |
Cost of Revenue | |||||
Gross Profit | -0.23 | -0.553 | -0.535 | -0.19 | -0.181 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3.77 | 4.26 | 2.49 | 5.03 | 6.72 |
Operating Profit | -2.3 | -3.8 | -2.38 | -5.03 | -6.72 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -3.51 | -5.23 | -4.05 | -13.5 | -6.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.51 | -5.23 | -4.05 | -13.5 | -6.9 |
Net Income Before Extraordinary Items | |||||
Net Income | -3.51 | -5.23 | -4.05 | -13.5 | -6.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.51 | -5.23 | -4.05 | -13.5 | -6.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -7.77 | -11.6 | -8.97 | -33.7 | -13.8 |
Dividends per Share |